More than 80 devices are available / under development for the delivery of various pharmacological interventions, via a variety of routes, for the treatment of diabetes, claims Roots Analysis

 

Stakeholders engaged in this domain are presently focusing on introducing advanced features, such as integrated continuous glucose monitoring (CGM) systems, artificial intelligence (AI) enabled algorithms, provisions for audiovisual / tactile feedback, and automatic drug reconstitution features. Such efforts are primarily directed towards differentiating proprietary offerings within a highlight competitive market landscape, and are expected to drive the market’s growth over the coming years.

• An overview of the current market landscape of diabetes drug delivery devices available for delivery of insulin and non-insulin drugs, including information on device specifications, such as type of device (insulin pump, pen-injector / autoinjector, jet injector, microneedle patch, nasal delivery system, insulin port, oral delivery system and inhalation device), stage of development (marketed, clinical and preclinical), route of administration (subcutaneous, intramuscular, transdermal, oral, intranasal and others), mode of drug delivery (invasive, minimally invasive and non-invasive), needle attributes (needleless, detachable needle, cannula, hidden needle and fixed needle), type of drug delivery system (mechanical method and electrical method), drug administration speed (fast and slow), device usability (disposable, reusable and reusable (disposable components)), diabetes type (type I diabetes, type II diabetes and diabetes type (unspecified)) and type of drug (insulin and non-insulin). In addition, the report present the details of the companies developing these devices, including information on type of developer (industry and non-industry), year of establishment, company size and location of headquarters. 
• A detailed competitiveness analysis of diabetes drug delivery devices based on various relevant parameters, such as supplier power (based on the experience / expertise of the developer) and product specifications (type of device, route of administration, diabetes type, needle attributes, availability of needle safety system, self-administration potential, mode of drug delivery, device usability, drug administration speed and development stage).
• An analysis of the partnerships that have been inked by the stakeholders in this domain, during the period between 2015 and 2020, covering technology integration agreements, product development agreements, distribution agreements, acquisitions, product commercialization agreements, supply agreements, licensing agreements, product development and commercialization agreements and other relevant types of deals.

 

To order this 240+ page report, which features 50+ figures and 70+ tables, please visit this link

 

The USD 31 million (by 2030) financial opportunity within the diabetes drug delivery devices market has been analyzed across the following segments:

• Type of Device
• Pen-Injectors
• Insulin Pumps
• Conventional Syringes
• Others

 

• Route of Administration
• Subcutaneous
• Intravenous
• Others

 

• Type of Diabetes
• Type 1
• Type 2

 

• Usability of the Device
• Disposable
• Reusable

 

• Key Geographies
• North America
• Europe
• Asia Pacific
• Rest of the World

 

The Diabetes Drug Delivery Devices Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

• Bigfoot Biomedical
• Debiotech
• Haselmeier
• Medtronic
• Novo Nordisk
• Roche
• SOOIL
• Ypsomed

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction
 

4. Current Market Landscape
 

5. Product Competitive Analysis
 

6. Partnerships and Collaborations
 

7. Company Profiles
 

8. Diabetes Drug Delivery Devices Related Initiatives of Big Pharma Players
 

9. Market Sizing and Opportunity Analysis
 

10. Concluding Remarks

 

11. Executive Insights

 

12. Appendix 1: Tabulated Data

 

13. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/diabetes-drug-delivery-devices-market.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]